1. van der Meer V, Wielders HP, Grootendorst DC, de Kanter JS, Sijpkens YW, Assendelft WJ, et al. Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners. 2010;60(581):884-90.
2. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLOS ONE.
2016;11(7):e0158765.
3. Bruck K, Stel VS, Gambaro G, Hallan S, Volzke H, Arnlov J, et al. CKD Prevalence Varies across the European General Population. Journal of the American Society of
Nephrology : JASN. 2016;27(7):2135-47.
4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003;41(1):1-12.
5. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Journal of the American Society of Nephrology : JASN.
2004;15(5):1307-15.
6. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. The New England journal of medicine. 1994;331(25):1675-9.
7. Mortality GBD, Causes of Death C. Global, regional, and national age-sex specific
all-cause and all-cause-specific mortality for 240 all-causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71.
8. Perazella MA, Khan S. Increased mortality in chronic kidney disease: a call to action.
The American journal of the medical sciences. 2006;331(3):150-3.
9. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease. Circulation.
2003;108(17):2154.
10. CKD Work Group. KDIGO. Kidney Disease: Improving Global Outcomes (KDIGO) 2012 [Available from:
http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf.
11. V R Biljak, L Honović, J Matica, B Krešić, S Šimić Vojak. The role of laboratory testing in detection and classification of chronic kidney disease: national recommendations. Biochemia Medica 2017;27(1):153-76.
12. Liao M-T, Sung C-C, Hung K-C, Wu C-C, Lo L, Lu K-C. Insulin Resistance in Patients with Chronic Kidney Disease. Journal of Biomedicine and Biotechnology. 2012;2012:691369.
13. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Journal of the American Society of Nephrology : JASN.
2005;16(7):2134-40.
14. Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2009;53(1):59-69.
15. CKD–MBD Work Group. KDIGO clinical practice guideline for the diagnosis,
16. Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, et al. FGF23 inhibits extra-renal synthesis of 1,25-dihydroxyvitamin D in human monocytes. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2013;28(1):46-55.
17. Bover J, Jara A, Trinidad P, Rodriguez M, Martin-Malo A, Felsenfeld AJ. The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia. Kidney international.
1994;46(2):310-7.
18. M.L. Bishop, E.P. Fody, L.E. Schoeff. Clinical Chemistry: Techniques, Principles, Correlations (6th ed.). Lippincott Williams and Wilkins; 2010.
19. Meyer TW, Hostetter TH. Uremia. New England Journal of Medicine.
2007;357(13):1316-25.
20. Bonomini V, Albertazzi A, Vangelista A, Bortolotti GC, Stefoni S, Scolari MP. Residual Renal Function and Effective Rehabilitation in Chronic Dialysis. Nephron. 1976;16(2):89-99.
21. Bonomini V, Feletti C, Scolari MP, Stefoni S. Benefits of early initiation of dialysis.
Kidney international Supplement. 1985;17:S57-9.
22. Tattersall J, Greenwood R, Farrington K. Urea kinetics and when to commence dialysis.
American journal of nephrology. 1995;15(4):283-9.
23. Korevaar JC, van Manen JG, Boeschoten EW, Dekker FW, Krediet RT. When to start dialysis treatment: where do we stand? Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 2005;25 Suppl 3:S69-72.
24. Winchester JF, Harbord N, Audia P, Dubrow A, Gruber S, Feinfeld D, et al. The 2006 K/DOQI guidelines for peritoneal dialysis adequacy are not adequate. Blood purification.
2007;25(1):103-5.
25. Obrador GT, Arora P, Kausz AT, Ruthazer R, Pereira BJ, Levey AS. Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population. Kidney
international. 1999;56(6):2227-35.
26. Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Annals of internal medicine.
2002;137(6):479-86.
27. Rosansky S, Glassock RJ, Clark WF. Early start of dialysis: a critical review. Clinical journal of the American Society of Nephrology : CJASN. 2011;6(5):1222-8.
28. Rosansky SJ, Clark WF, Eggers P, Glassock RJ. Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful? Kidney international.
2009;76(3):257-61.
29. Wright S, Klausner D, Baird B, Williams ME, Steinman T, Tang H, et al. Timing of Dialysis Initiation and Survival in ESRD. Clinical journal of the American Society of Nephrology : CJASN. 2010;5(10):1828-35.
30. Wilson B, Harwood L, Locking-Cusolito H, Chen SJ, Heidenheim P, Craik D, et al.
Optimal timing of initiation of chronic hemodialysis? Hemodialysis international International Symposium on Home Hemodialysis. 2007;11(2):263-9.
31. Park JY, Yoo KD, Kim YC, Kim DK, Joo KW, Kang S-W, et al. Early dialysis initiation does not improve clinical outcomes in elderly end-stage renal disease patients: A multicenter prospective cohort study. PLoS ONE. 2017;12(4):e0175830.
32. Strippoli GFM, Tong A, Johnson DW, Schena FP, Craig JC. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients. Cochrane Database of Systematic Reviews. 2004(4).
33. Bergjan M, Schaepe C. Educational strategies and challenges in peritoneal dialysis: a qualitative study of renal nurses' experiences. Journal of clinical nursing.
2016;25(11-12):1729-peritonitis incidence in chronic peritoneal dialysis patients: a retrospective cohort study with 12-year follow-up. Peritoneal dialysis international : journal of the International Society for
Peritoneal Dialysis. 2013;33(5):552-8.
35. Mizuno M, Ito Y, Suzuki Y, Sakata F, Saka Y, Hiramatsu T, et al. Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry. Clinical and experimental nephrology. 2016;20(6):960-71.
36. Wong LP, Yamamoto KT, Reddy V, Cobb D, Chamberlin A, Pham H, et al. Patient education and care for peritoneal dialysis catheter placement: a quality improvement study.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
2014;34(1):12-23.
37. Yang ZK, Han QF, Zhu TY, Ren YP, Chen JH, Zhao HP, et al. The associations between the family education and mortality of patients on peritoneal dialysis. PLoS One.
2014;9(5):e95894.
38. Heimburger O, PG. B. Handbook of dialysis, Apparatus for peritoneal dialysis. 4th ed:
Lippincott, Williams & Wilkins; 2007.
39. Nowak Z, Laudanski K. The perception of the illness with subsequent outcome measure in more favorable in continuos peritoneal dialysis vs hemodialysis in the framework of
appraisal model of stress. International journal of medical sciences. 2014;11(3):291-7.
40. Tokgoz B. Clinical advantages of peritoneal dialysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 2009;29 Suppl 2:S59-61.
41. Srivaths P, Krishnamurthy R, Brunner L, Logan B, Bennett M, Ma Q, et al. Cardiac calcifications are more prevalent in children receiving hemodialysis than peritoneal dialysis.
Clinical nephrology. 2014;81(4):231-7.
42. Salamon K, Woods J, Paul E, Huggins C. Peritoneal dialysis patients have higher prevalence of gastrointestinal symptoms than hemodialysis patients. Journal of renal nutrition :
the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2013;23(2):114-8.
43. Sens F, Schott-Pethelaz AM, Labeeuw M, Colin C, Villar E. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney international. 2011;80(9):970-7.
44. Cornelis T, Usvyat LA, Tordoir JH, Wang Y, Wong M, Leunissen KM, et al. Vascular access vulnerability in intensive hemodialysis: a significant Achilles' heel? Blood purification.
2014;37(3):222-8.
45. Hicks CW, Canner JK, Arhuidese I, Zarkowsky DS, Qazi U, Reifsnyder T, et al.
Mortality benefits of different hemodialysis access types are age dependent. Journal of vascular surgery. 2015;61(2):449-56.
46. Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. Journal of the American Society of Nephrology : JASN. 2013;24(3):465-73.
47. Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, et al. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. American Journal of Kidney Diseases.66(5):884-930.
48. Kim Y, Evangelista LS, Park YG. Anxiolytic Effects of Music Interventions in Patients Receiving Incenter Hemodialysis: A Systematic Review and Meta-Analysis. Nephrology nursing journal : journal of the American Nephrology Nurses' Association. 2015;42(4):339-47;
quiz 48.
49. Koca Kutlu A, Eren AG. Effects of music on complications during hemodialysis for chronic renal failure patients. Hemodialysis international International Symposium on Home
in patients with end-stage renal disease receiving hemodialysis versus peritoneal dialysis. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2015;26(2):392-7.
51. Wu B, Wang M, Gan L, Zhao H. Comparison of patient survival between hemodialysis and peritoneal dialysis in a single Chinese center. International urology and nephrology.
2014;46(12):2403-7.
52. Neovius M, Jacobson SH, Eriksson JK, Elinder CG, Hylander B. Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study. BMJ open.
2014;4(2):e004251.
53. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, et al.
Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant. New England Journal of Medicine. 1999;341(23):1725-30.
54. Hart A, Smith JM, Skeans MA, Gustafson SK, Stewart DE, Cherikh WS, et al.
OPTN/SRTR 2015 Annual Data Report: Kidney. American Journal of Transplantation.
2017;17:21-116.
55. de Groot IB, Veen JI, van der Boog PJ, van Dijk S, Stiggelbout AM, Marang-van de Mheen PJ. Difference in quality of life, fatigue and societal participation between living and deceased donor kidney transplant recipients. Clinical transplantation. 2013;27(4):E415-23.
56. Nemati E, Einollahi B, Lesan Pezeshki M, Porfarziani V, Fattahi MR. Does Kidney Transplantation With Deceased or Living Donor Affect Graft Survival? Nephro-urology Monthly. 2014;6(4):e12182.
57. Kandaswamy R, Kasiske B, Ibrahim H, Matas AJ. Living or deceased donor kidney transplants for candidates with significant extrarenal morbidity. Clinical transplantation.
2006;20(3):346-50.
58. Kute VB, Vanikar AV, Shah PR, Gumber MR, Patel HV, Engineer DP, et al. Does donor-recipient age difference matter in outcome of kidney transplantation? Implications for kidney paired donation. Renal failure. 2014;36(3):378-83.
59. Resende L, Guerra J, Santana A, Mil-Homens C, Abreu F, da Costa AG. Impact of donor age on renal allograft function and survival. Transplantation proceedings. 2009;41(3):794-6.
60. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and
recipients of a first cadaveric transplant. The New England journal of medicine.
1999;341(23):1725-30.
61. Bacak Kocman I, Perić, M., Goluža, E., Kocman, I., Kaštelan, Ž., Pasini, J., Kes, P., Basic Jukic, N. TRANSPLANTACIJA BUBREGA KOD STARIJIH OSOBA – VAŽNOST OBILJEŽJA DARIVATELJA I PRIMATELJA. Acta medica Croatica. 2012;66(3): 203-6.
62. Grams ME, Massie AB, Coresh J, Segev DL. Trends in the timing of pre-emptive kidney transplantation. Journal of the American Society of Nephrology : JASN. 2011;22(9):1615-20.
63. Jay CL, Dean PG, Helmick RA, Stegall MD. Reassessing Preemptive Kidney Transplantation in the United States: Are We Making Progress?
Transplantation.2016;100(5):1120-7.
64. Rački S B-JN, Kes P,, Sabljar-Matovinović M R-GI, Bušić M, i sur. Nacionalne smjernice za obradu i odabir primatelja i darovatelja bubrega usklađene sa smjernicama 2013 ERBP guideline on the management and evaluation of kidney donor and recipient. In: Hrvatske MzR, editor. Zagreb2016.
65. Gill JS, Tinckam K, Fortin MC, Rose C, Shick-Makaroff K, Young K, et al. Reciprocity to Increase Participation of Compatible Living Donor and Recipient Pairs in Kidney Paired
66. Barnett AN, Manook M, Nagendran M, Kenchayikoppad S, Vaughan R, Dorling A, et al.
Tailored desensitization strategies in ABO blood group antibody incompatible renal
transplantation. Transplant international : official journal of the European Society for Organ Transplantation. 2014;27(2):187-96.
67. Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, et al. Evaluation of
intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
Journal of the American Society of Nephrology : JASN. 2004;15(12):3256-62.
68. Masterson R, Hughes P, Walker RG, Hogan C, Haeusler M, Robertson AR, et al. ABO incompatible renal transplantation without antibody removal using conventional
immunosuppression alone. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
2014;14(12):2807-13.
69. Bašić Jukić N, Kaštelan Ž i sur. Transplantacija bubrega: Medicinska naklada; 2016.
70. Pieloch D, Dombrovskiy V, Osband AJ, Lebowitz J, Laskow DA. Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2014;24(1):50-7.
71. Panocchia N, Bossola M, Vivanti G. Transplantation and Mental Retardation: What Is the Meaning of a Discrimination? American Journal of Transplantation. 2010;10(4):727-30.
72. Bhowmik DM, Dinda AK, Mahanta P, Agarwal SK. The evolution of the Banff
classification schema for diagnosing renal allograft rejection and its implications for clinicians.
Indian journal of nephrology. 2010;20(1):2-8.
73. Haas M. The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations. American journal of
transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2016;16(5):1352-7.
74. Tong A, Budde K, Gill J, Josephson MA, Marson L, Pruett TL, et al. Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation. Transplantation Direct. 2016;2(6):e79.
75. Arnold R, Issar T, Krishnan AV, Pussell BA. Neurological complications in chronic kidney disease. JRSM Cardiovascular Disease. 2016;5:2048004016677687.
76. Bernstein L. People with autism, intellectual disabilities fight bias in transplants: The Washington post; 2017. Dostupno na: https://www.washingtonpost.com/national/health-
science/people-with-autism-intellectual-disabilities-fight-bias-in-transplants/2017/03/04/756ff5b8-feb2-11e6-8f41-ea6ed597e4ca_story.html?
utm_term=.96f796703f19.
77. Anderson P. Deciding Who Gets Donor Organs: How Important Is Cognition? : Medscape; 2017. Dostupno na: http://www.medscape.com/viewarticle/875012.
78. Is dying better than dialysis for a woman with Down syndrome? Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees.
1994;3(2):270-1; discussion 1-6.
79. Kujdych N, Lowe DA, Sparks J, Dottes A, Crook ED. Dignity or denial? Decisions regarding initiation of dialysis and medical therapy in the institutionalized severely mentally retarded. The American journal of the medical sciences. 2000;320(6):374-8.
80. Aksu N, Yavascan O, Anil M, Kara OD, Bal A, Anil AB. Chronic peritoneal dialysis in children with special needs or social disadvantage or both: contraindications are not always contraindications. Peritoneal dialysis international : journal of the International Society for
hemodialysis in patients with mental retardation. Renal failure. 2008;30(1):63-5.
82. Khurana S KV, Haque S, . Intellectual disability impedes decision-making in organ transplantation. Current Psychiatry. 2016;15(2):e1-e3.
83. Levenson JL, Olbrisch ME. Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation.
Psychosomatics. 1993;34(4):314-23.
84. Richards CT, Crawley LM, Magnus D. Use of neurodevelopmental delay in pediatric solid organ transplant listing decisions: inconsistencies in standards across major pediatric transplant centers. Pediatric transplantation. 2009;13(7):843-50.
85. Galante NZ, Dib GA, Medina-Pestana JO. Severe intellectual disability does not
preclude renal transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2010;25(8):2753-7.
86. Martens MA, Jones L, Reiss S. Organ transplantation, organ donation and mental retardation. Pediatric transplantation. 2006;10(6):658-64.
87. Wightman A, Bartlett HL, Zhao Q, Smith JM. Prevalence and outcomes of heart transplantation in children with intellectual disability. Pediatric transplantation. 2017;21(2).
88. Chen A, Farney A, Russell GB, Nicolotti L, Stratta R, Rogers J, et al. Severe intellectual disability is not a contraindication to kidney transplantation in children. Pediatric
transplantation. 2017;21(3).
89. Samelson-Jones E, Mancini DM, Shapiro PA. Cardiac transplantation in adult patients with mental retardation: do outcomes support consensus guidelines? Psychosomatics.
2012;53(2):133-8.
90. Ohta T, Motoyama O, Takahashi K, Hattori M, Shishido S, Wada N, et al. Kidney transplantation in pediatric recipients with mental retardation: clinical results of a multicenter
experience in Japan. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2006;47(3):518-27.
91. Goel AN, Iyengar A, Schowengerdt K, Fiore AC, Huddleston CB. Heart transplantation in children with intellectual disability: An analysis of the UNOS database. Pediatric
transplantation. 2017;21(2).
92. Kappel B. Lives Worth Saving: Organ Transplantation and People with Disabilities:
Department of administration, Council of developmental disabilities; 2004 [Available from:
http://mn.gov/mnddc//news/newsitems/transplant.html.
93. Diament M. Disability No Reason To Deny Organ Transplants, Lawmakers Say:
Disability scoop; 2016. dostupno: https://www.disabilityscoop.com/2016/10/24/disability-organ-lawmakers/22920
94. Chan W, Bosch JA, Jones D, McTernan PG, Phillips AC, Borrows R. Obesity in kidney transplantation. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 2014;24(1):1-12.
95. Hill CJ, Courtney AE, Cardwell CR, Maxwell AP, Lucarelli G, Veroux M, et al.
Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2015;30(8):1403-11.
96. Wissing KM, Pipeleers L. Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment. Transplantation reviews (Orlando, Fla).
2014;28(2):37-46.